SCHEMBL9158908

SCHEMBL9158908

NCCCCC(NC(=O)c1cnccn1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LONP1 P36776 12/20 0.48
PSMB11 A5LHX3 5/20 0.46
PSMA7 O14818 5/20 0.46
PSMB1 P20618 5/20 0.46
PSMA1 P25786 5/20 0.46
PSMA2 P25787 5/20 0.46
PSMA3 P25788 5/20 0.46
PSMA4 P25789 5/20 0.46
PSMB8 P28062 5/20 0.46
PSMB9 P28065 5/20 0.46
PSMA5 P28066 5/20 0.46
PSMB4 P28070 5/20 0.46
PSMB6 P28072 5/20 0.46
PSMB5 P28074 5/20 0.46
PSMB10 P40306 5/20 0.46
PSMB3 P49720 5/20 0.46
PSMB2 P49721 5/20 0.46
PSMA6 P60900 5/20 0.46
PSMA8 Q8TAA3 5/20 0.46
PSMB7 Q99436 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9158915 1.00 LONP1 (0.48) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL29889201 0.96 LONP1 (0.49) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL25286303 0.96 LONP1 (0.49) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL25286304 0.96 LONP1 (0.49) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL2151194 0.83 LONP1 (0.46) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL2151203 0.83 LONP1 (0.46) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL9830710 0.82 LONP1 (0.63) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL9830718 0.82 LONP1 (0.63) LONP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL825451 0.82 CTSK (0.64) FOLH1CTSK
SCHEMBL4404268 0.82 CTSK (0.64) FOLH1CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377665-B1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE UNIV TEXAS (US) 1995-07-12 EP disclosed
EP-0536203-B1 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS APPLIED RESEARCH SYSTEMS (AN) 1995-02-08 EP disclosed
WO-1991019743-A2 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1991-12-26 WO disclosed
EP-0377665-A1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE. UNIV TEXAS (US) 1990-07-18 EP disclosed
WO-1989009786-A1 PEPTIDE DERIVATIVES SANDOZ AG (CH) 1989-10-19 WO disclosed
WO-1989001944-A1 EFFECTIVE ANTAGONISTS OF THE LUTEINIZING HORMONE RELEASING HORMONE WHICH RELEASE NEGLIGIBLE HISTAMINE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1989-03-09 WO disclosed